retatrutide triple agonist gip glp-1 glucagon Retatrutide: The "Triple G" Peptide That Could Rival Bariatric Surgery (And Why You Shouldn't Wait) ly3437943 retatrutide triple agonist glp-1

V. Kh. Khavinson, N. S. Linkova, and S. I. Tarnovskaya, Short Peptides Regulate Gene Expression, Springer Science and Business Media LLC, Dec. 2016. doi: 10.1007/s10517-016-3596-7

Join countless others who have unlocked the secret to radiant skin and enjoy every moment of your skincare journey

In 56-week studies, patients taking Contrave alongside diet and exercise lost an average of 5-9% of their body weight, compared to 1-5% with a placebo, meaning the medication contributed roughly 4-5 percentage points of additional weight loss.4,5 About 46% of patients on Contrave achieved at least 5% weight loss by week 16

Senna (Ex-Lax): Stimulant laxative for occasional use when nothing else works

Amer Chem Soc Polymer Prepr

The digestive side effects can stack